ENDOGEN ApS: Financial statements 2019
CVR: 29813337
ENDOGEN ApS (CVR 29813337) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -47,897 and a net result of DKK -48,651 compared with DKK -25,908 the year before. Equity amounted to DKK 97,270. The solvency ratio was 88.6%. The company had 1 employee in the financial year.
- Gross Profit
- -47,897 kr.
- Profit/Loss
- -48,651 kr.
- Equity
- 97,270 kr.
- Total Assets
- 109,770 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -48 t. | -49 t. | 97 t. | 1 |
| 2018 | - | -26 t. | -26 t. | 83 t. | 1 |
| 2017 | 0 | -7 t. | -7 t. | 36 t. | - |
| 2016 | 0 | -13 t. | -14 t. | 43 t. | - |
| 2015 | 19 t. | -16 t. | -16 t. | 56 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2019
ENDOGEN ApS has published its annual report for 2018. Gross profit came to DKK -25,583, and the net result was DKK -25,908.
As of January 10, 2019, Simon Glerup Pedersen is registered as director of ENDOGEN ApS.
About ENDOGEN ApS
ENDOGEN ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Glerup Pedersen. The company is owned by KOLLISION ApS, Camilla Gustafsen Consulting ApS and Simon Glerup Consulting ApS. In 2025, the company reported a gross profit of DKK 113,212 and a net result of DKK -79,499 compared with DKK -22,939 the year before. Equity amounted to DKK -82,428.
